Evidence map›Paper›PMID 39425812›Full record

ReviewCurrent cardiology reports2024

Transcatheter Myotomy for Hypertrophic Obstructive Cardiomyopathy.

Barbara Danek, David Elison, Christine J Chung, James M McCabe

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current cardiology reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Barbara DanekUniversity of Washington Medical Center, 1959 NE Pacific St, Seattle, WA, 98195, USA.
David ElisonUniversity of Washington Medical Center, 1959 NE Pacific St, Seattle, WA, 98195, USA.
Christine J ChungUniversity of Washington Medical Center, 1959 NE Pacific St, Seattle, WA, 98195, USA.
James M McCabeUniversity of Washington Medical Center, 1959 NE Pacific St, Seattle, WA, 98195, USA. jmmccabe@cardiology.washington.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewTo describe the emerging role of transcatheter septal myotomy in the treatment of hypertrophic obstructive cardiomyopathy. RECENT

findingsTranscatheter septal myotomy was developed to address risk of LVOT obstruction during TMVR, however it has been performed in patients with LVOT obstruction related to hypertrophic cardiomyopathy, in whom it improves symptoms, reduces LVOT gradients, and is associated with low incidence of procedural complications. Transcatheter myotomy is a novel approach to address LVOT obstruction related to hypertrophic cardiomyopathy in patients who are not favorable surgical candidates. The risk of conduction abnormalities with transcatheter septal myotomy appears low. Research is needed to define optimal patient selection and long-term outcomes.

Indexed as

Cardiac CatheterizationCardiomyopathy, HypertrophicMyotomyHeart SeptumHumansPatient SelectionTreatment OutcomeVentricular Outflow ObstructionHypertrophic obstructive cardiomyopathyLeft ventricular outflow tract obstructionTranscatheter electrosurgeryTranscatheter myotomy (SESAME)

Identifiers

PMID39425812

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.